Why this fundie is calling the peak for CBA shares

Jun Bei Liu is the lead Portfolio Manager at Tribeca Alpha Plus Fund and is set to present an investment idea at the Sohn Hearts & Minds Conference in Hobart on November 18.

Why this fundie is calling the peak for CBA shares

October 27, 2022
Jun Bei Liu is the lead Portfolio Manager at Tribeca Alpha Plus Fund and is set to present an investment idea at the Sohn Hearts & Minds Conference in Hobart on November 18.
Read Transcript

How are you reading the Wall Street rally on hopes for a slower pace of rate rises?

The rally across equities is driven by two factors: expectations of slowing rate rises in the US and extreme bearish positioning by investors. But it’s premature to think that rate rises by the US Federal Reserve will stall soon.

Inflation in the US remains stubbornly high with wages continuing to rise to uncomfortable levels. Despite some relief from lower commodity prices, the tight rental market continues to put upward pressure on the CPI. We are expecting another 75 basis point rise in November, followed by a 50 basis point rise in December. We are unlikely to see a peak in interest rates in the US until early next year, by which time we should begin to see real economic weakness.

We think many investors have been far too cautious and are sitting on large cash balances. As a long-short manager, this market is presenting us with some of the best buying opportunities in many years for many quality businesses. Our view is that some of those excess cash balances will be redeployed into the market over the next six months which, together with a pick up in M&A activity early next year, should underpin the Australian market.

Which stocks are you looking at adding to, or snatching up, since valuations have fallen?

Since the sell-off in June, we have added REA Group, Johns Lyng Group and NextDC to the portfolio. We are looking for quality companies with an established franchise and track record that has been unfairly sold off by the market as investors hide in safe havens. A lack of confidence by market participants are presenting unprecedented opportunities.

What’s the thinking behind being underweight CBA?

We are net neutral the Australian banking sector. Our view is that trading conditions for banks are probably as good as it gets, with rising interest rates, steady mortgage growth and a benign credit environment. As a long-short manager, we look at this sector in a relative order. We prefer some of the cheaper banks, such as ANZ, which will report its earnings with a good tailwind and we pair it with one of the more expensive banks such as CBA.

With an expected slowing of economic activity, banks – like many parts of the economy such as building materials and consumer discretionary – will be under more pressure. Meanwhile, the CBA share price continues to trade close to an all-time high versus building materials, for instance, which are down 30 per cent.

To us, this means a falling share price in the not so distant future.

Are lithium stocks too frothy?

We do think lithium stocks are frothy. While the medium- to long-term prospect of demand for lithium-ion batteries remains strong, in the shorter term they have run up too fast, too high. We have been early investors in many of those lithium names and we have generated enormous return. We are now taking profits in the space and recycling capital into some of the underperforming names and other sectors.

Where to for Ramsay Health Care after KKR walked away from takeover talks?

Ramsay is probably one of very few deep value stocks currently trading on the ASX. With recovery on the way, its earnings will compound 25 per cent over the next three years and medium term growth will be supported by capital deployment into field projects, and increased waiting lists support winning public sector work. Private hospitals are a highly sought after infrastructure-like asset.

Ramsay is now trading at a 40 per cent discount to the KKR bid, and it has substantial premium property on the balance sheet that can be split into a separate structure to create value.

Any TV shows or podcasts you’re into lately?

With two young children, I am all about pop culture. Stranger Things is one we have followed closely. Netflix has now become our daily go-to in addition to many other streaming services.

Best dining in Sydney?

One of my favourite restaurants in Sydney would have to be Chin Chin at Surry Hills. Its yummy fusion food with vibrant decor is a great place for catching up with friends. Another favourite in the nearby streets is the wine bar WyNo X Bodega. It is a tiny wine bar with sharing tables, and they have some of the best wines around the world for tasting, and also serve some of the best food to go with those wines.

The Australian Financial Review is a media partner of sohnheartsandminds.com.au

 

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by AFR, published on 27 October 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

How are you reading the Wall Street rally on hopes for a slower pace of rate rises?

The rally across equities is driven by two factors: expectations of slowing rate rises in the US and extreme bearish positioning by investors. But it’s premature to think that rate rises by the US Federal Reserve will stall soon.

Inflation in the US remains stubbornly high with wages continuing to rise to uncomfortable levels. Despite some relief from lower commodity prices, the tight rental market continues to put upward pressure on the CPI. We are expecting another 75 basis point rise in November, followed by a 50 basis point rise in December. We are unlikely to see a peak in interest rates in the US until early next year, by which time we should begin to see real economic weakness.

We think many investors have been far too cautious and are sitting on large cash balances. As a long-short manager, this market is presenting us with some of the best buying opportunities in many years for many quality businesses. Our view is that some of those excess cash balances will be redeployed into the market over the next six months which, together with a pick up in M&A activity early next year, should underpin the Australian market.

Which stocks are you looking at adding to, or snatching up, since valuations have fallen?

Since the sell-off in June, we have added REA Group, Johns Lyng Group and NextDC to the portfolio. We are looking for quality companies with an established franchise and track record that has been unfairly sold off by the market as investors hide in safe havens. A lack of confidence by market participants are presenting unprecedented opportunities.

What’s the thinking behind being underweight CBA?

We are net neutral the Australian banking sector. Our view is that trading conditions for banks are probably as good as it gets, with rising interest rates, steady mortgage growth and a benign credit environment. As a long-short manager, we look at this sector in a relative order. We prefer some of the cheaper banks, such as ANZ, which will report its earnings with a good tailwind and we pair it with one of the more expensive banks such as CBA.

With an expected slowing of economic activity, banks – like many parts of the economy such as building materials and consumer discretionary – will be under more pressure. Meanwhile, the CBA share price continues to trade close to an all-time high versus building materials, for instance, which are down 30 per cent.

To us, this means a falling share price in the not so distant future.

Are lithium stocks too frothy?

We do think lithium stocks are frothy. While the medium- to long-term prospect of demand for lithium-ion batteries remains strong, in the shorter term they have run up too fast, too high. We have been early investors in many of those lithium names and we have generated enormous return. We are now taking profits in the space and recycling capital into some of the underperforming names and other sectors.

Where to for Ramsay Health Care after KKR walked away from takeover talks?

Ramsay is probably one of very few deep value stocks currently trading on the ASX. With recovery on the way, its earnings will compound 25 per cent over the next three years and medium term growth will be supported by capital deployment into field projects, and increased waiting lists support winning public sector work. Private hospitals are a highly sought after infrastructure-like asset.

Ramsay is now trading at a 40 per cent discount to the KKR bid, and it has substantial premium property on the balance sheet that can be split into a separate structure to create value.

Any TV shows or podcasts you’re into lately?

With two young children, I am all about pop culture. Stranger Things is one we have followed closely. Netflix has now become our daily go-to in addition to many other streaming services.

Best dining in Sydney?

One of my favourite restaurants in Sydney would have to be Chin Chin at Surry Hills. Its yummy fusion food with vibrant decor is a great place for catching up with friends. Another favourite in the nearby streets is the wine bar WyNo X Bodega. It is a tiny wine bar with sharing tables, and they have some of the best wines around the world for tasting, and also serve some of the best food to go with those wines.

The Australian Financial Review is a media partner of sohnheartsandminds.com.au

 

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by AFR, published on 27 October 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Oct 27, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 3, 2025

How to beat the market without owning Nvidia shares

Vihari Ross' global fund returned more than 20 per cent in the year to September 30 versus about 10 per cent for the benchmark without owning Nvidia, Meta, Tesla, Apple or Broadcom.

Read More
November 12, 2025

Square Peg's Ben Hensman names top picks in a hot tech sector

“We’re really looking for people who have that strong growth arc. Even though they’ve reached material scale, they’re still changing and moulding their company to move really fast, and they’re curious.”

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

'Here to pitch the parent company': Jim Chalmers' Sohn pick

The federal treasurer got into the spirit of the Sohn Hearts & Minds event with a big-picture investment tip – and a dig at our nation’s fundies.

Read More
November 14, 2025

Forget Trump volatility says top investor and focus on China threat to Australia

Australian investors should be more worried about China than sweating on Federal Reserve independence and other market obsessions to do with Donald Trump, says billionaire conservative Baron Michael Hintze.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

Activism without proxy fights is like ‘Catholicism without hell’: Loeb

An older, wiser Dan Loeb reckons his activist approach has changed, but the Wall Street icon will never put away the big stick.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

Net zero move good, but Libs need ‘north star’: Lord Hintze

Michael Hintze, one of Australia’s richest international ­billionaires and donor to ­conservative parties, says the Liberals are lacking a “north star” but dumping net zero was a smart move.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

Third Point’s Loeb leads bullish investors despite stock slump

Major investors say the global economy is strong enough to withstand a bubble in artificial intelligence and turmoil in private credit markets despite a sharp fall on Wall Street and the ASX over the past week.

Read More
November 14, 2025

The 9 hottest stock tips from this year’s Sohn fund managers

Defying markets gloom, top investment chiefs pitched their best global ideas, from an “OG in AI” to a retirement giant.

Read More
Picture: Katje FordPicture: Katje FordPicture: Katje FordPicture: Katje Ford
November 14, 2025

10 top stock picks from Sohn Hearts & Minds conference 2025

Global fund managers gathered at the 2025 Sohn Hearts & Minds conference to pitch their best stock ideas. Here are all 10 tips in the order they were presented.

Read More
Photo: Kajie FordPhoto: Kajie FordPhoto: Kajie FordPhoto: Kajie Ford
November 18, 2025

Anthony Scaramucci says everyone in Trump's orbit hates him

“The Mooch”, as he’s affectionately known, is a man in high demand. He’s flown into Sydney to headline the Sohn Hearts & Minds conference at the Opera House, an investment community jamboree that raises money for charity. He landed in London the night before, and will leave Sydney the next day for the brutal 24-hour return to New York.

Read More
November 14, 2025

Queenstown to host 2026 Sohn Hearts & Minds Conference

We're thrilled to announce Queenstown, New Zealand, as the destination for the 2026 Investment Leaders Conference, to be held on Friday 6 November.

Read More
November 23, 2025

Nvidia's wild swings and 11 Sohn Hearts & Minds stock picks reviewed

Equity Mates reviewed the high conviction stock picks presented at the 2025 Sohn Hearts & Minds Conference.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.